Globalstar Misses Q3 2026 Estimates as Revenue Falls 4.0% to $70.9M

Globalstar (GSAT) missed estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $70.9 million, down 4.0% from a year earlier, below the $74.5 million estimate, and adjusted EPS was -$0.14, down 1300% from a year earlier, below the -$0.12 estimate.

Shares fell 0.7% in premarket trading as of 7:58 a.m. ET, to $84.02 from a $84.58 close.

Q3 2026 scorecard

By our calculation, revenue was $3.5 million below the estimate and adjusted EPS was $0.02 below it. The QoQ column compares with the previous quarter's revenue of $64.8 million and adjusted EPS of -$0.23. The YoY column compares with $73.8 million and -$0.01 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 1 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $73.8 million, $72.0 million, $70.1 million, $64.8 million and $70.9 million.

What to watch

• Next-quarter estimates. Consensus calls for EPS of -$0.12 and revenue of $76.4 million next quarter, based on 1 analyst.
• Next report. Globalstar is next expected to report on March 3, 2027.
• Revenue growth. Whether revenue stabilizes after this quarter's 4.0% decline from a year earlier to $70.9 million.
• Related coverage. See our reports on Intellia Therapeutics, Insight Enterprises, Zenas BioPharma and Virtu Financial.

Sources: Results are from Globalstar's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Globalstar's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.